Zobrazeno 41 - 50
of 75
pro vyhledávání: '"Silvia Veneroni"'
Autor:
Angelo Paradiso, Rosella Silvestrini, Maria Grazia Daidone, Vera Cappelletti, M. Correale, Giovanni Di Fronzo, Dino Amadori, Angela Riccobon, Silvia Veneroni
Publikováno v:
Breast Cancer Research and Treatment. 26:7-13
The expression of cathepsin D was evaluated by immunohistochemistry on histologic sections from formalin-fixed samples in a series of 436 primary breast cancers. The fraction of cathepsin D-positive tumor cells was not related to tumor size or hormon
Autor:
Valeria Musella, Loris De Cecco, Silvia Veneroni, Maria Grazia Daidone, Manuela Gariboldi, Maurizio Callari, Vera Cappelletti, Marco A. Pierotti, Patrizia Miodini
Publikováno v:
Breast cancer research and treatment. 127(3)
Male breast cancer (MBC) is a poorly characterized disease because of its rarity. Clinical management is based on results obtained from randomized trials conducted in women notwithstanding data in the literature suggesting relevant gender-associated
Autor:
Silvia Veneroni, Rosella Silvestrini, Patrizia Boracchi, Roberto Giardini, G. Messina-Gabrielli, Aurora Costa
Publikováno v:
British Journal of Cancer
Scopus-Elsevier
Scopus-Elsevier
The 3H-thymidine labelling index (3H-dT LI) of cell suspensions from fresh material and the flow cytometric S-phase (FCM-S) of nuclei recovered from paraffin blocks were determined on the same pathologic lymph node specimen for 190 non-Hodgkin's lymp
Autor:
Guerrino Mezzanotte, Giuseppe Muscolino, Rosella Silvestrini, Cosimo Lequaglie, Gianni Ravasi, Aurora Costa, Silvia Veneroni
Publikováno v:
Lung Cancer. 7:165-170
Cell kinetics, evaluated as 3H-thymidine labeling index ([3H]TdR LI), was assessed in 72 previously untreated non-small-cell lung cancers (NSCLC) from patients operated on during the period 1978 to 1982 at the Istituto Nazionale Tumori of Milan. Path
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 14(6)
Autor:
Mamoun Younes, Silvia Veneroni, Saro Oriana, Vera Cappelletti, Gorana Tomasic, Danila Coradini, Maria Grazia Daidone
Publikováno v:
Journal of the National Cancer Institute. 95(8)
Publikováno v:
Critical reviews in oncology/hematology. 45(3)
A biological characterisation carried out on 14,007 primary breast cancers provided evidence in favour of a relation between advanced age and favourable features (positivity for oestrogen/progesterone receptors, low proliferative rate, absence of p53
Autor:
Eugenio Scanziani, Silvia Veneroni, Ezio Bombardelli, Diletta Laccabue, Paola Perego, Franco Zunino, Massimo Zucchetti, Graziella Pratesi, Maurizio D'Incalci, Marco Zaffaroni, Monica Tortoreto
Publikováno v:
Cancer. 92(12)
BACKGROUND The development of effective chemotherapy for central nervous system tumors is hampered by the blood-brain barrier and by limited drug diffusion in the brain tissue. BAY 59-8862 is a new taxane analog that was selected and developed for it
Publikováno v:
Endocrine-related cancer. 6(1)
Interest in translational studies aimed at investigating the role of biologic markers in predicting clinical outcome of breast cancer patients and, in particular, response to specific treatments, has progressively increased. Among biologic variables
Autor:
E. Benini, Gabriele Martelli, Maria Grazia Daidone, Rosella Silvestrini, Gorana Tomasic, G. De Palo, Silvia Veneroni, A Luisi
Publikováno v:
British Journal of Cancer
Scopus-Elsevier
Scopus-Elsevier
The predictive role of tumour proliferative rate and expression of p53, bcl-2 and bax proteins, alone and in association with tumour size, nodal involvement and oestrogen receptors (ER), was analysed on 145 elderly patients (≥70 years of age) with